Aridis Pharmaceuticals Inc (ARDS)

0.077 +0.007 (+9.84%)
Close USD Disclaimer

ARDS Financial Summary

Aridis Pharmaceuticals, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported revenue was USD 0.417 million compared to USD 0.399 million a year ago. Net loss was USD 0.083 million compared to USD 8.24 million a year ago.For the nine months, revenue was USD 21.15 million compared to USD 1.88 million a year ago. Net income was USD 5.25 million compared to net loss of USD 23.98 million a year ago. Basic earnings per share from continuing operations was USD 0.15 compared to basic loss per share from continuing operations of USD 1.35 a year ago. Diluted earnings per share from continuing operations was USD 0.11 compared to diluted loss per share from continuing operations of USD 1.35 a year ago.
TTM
Trailing Twelve Months
MRQ
Most Recent Quarter
ARDS
Gross margin TTM 23.28%
Operating margin TTM -2.93%
Net Profit margin TTM -5.11%
Return on Investment TTM 0%
Total Revenue
Net Income
Title
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Total Revenue 0.42 19.65 1.08 1.21
Gross Profit 0.42 14.98 -4.45 -5.57
Operating Income -0.87 13.67 -6.26 -7.19
Net Income -0.08 12.14 -6.82 -6.39
Clear All
0Selected
Please try another search
ARDS
Quick Ratio MRQ 0.03
Current Ratio MRQ 0.24
LT Debt to Equity MRQ 0%
Total Debt to Equity MRQ -41.01%
Total Assets
Total Liabilities
Title
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Total Assets 6.48 9.43 14.70
Total Liabilities 21.40 37.32 38.93
Total Equity -14.91 -14.91 -27.88 -24.23
Clear All
0Selected
Please try another search
ARDS
Cash Flow/Share TTM -0.4
Revenue/Share TTM 0.5
Operating Cash Flow -
Cash
Net Change in Cash
Title
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Cash From Operating Activities -4.34 -4 -8.56
Cash From Investing Activities 0.01 -0.05
Cash From Financing Activities 3.03 0.26 11.03
Net Change in Cash -1.30 -3.74 2.43
Clear All
0Selected
Please try another search

* In Millions of USD (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles